http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0779814-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f353af12db08b6b7836ed3789d83b8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
filingDate 1995-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34addde5a66dfedbd2c2cc235c4e4494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e88790188682207cb47a7ffdd7f65ac9
publicationDate 1997-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0779814-A1
titleOfInvention Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications
abstract Heparin compositions having an antithrombotic activity and virtually no hemorrhagic activity. The object of the invention is to eliminate the risk of bleeding associated with heparins while retaining their main properties. The compositions of the invention (S1, S2, S3) therefore consist of heparin moieties such as those obtainable by the in vitro neutralization of a heparin with a protamine. The invention also concerns a method for the preparation of these compositions which are useful in preparing medicaments.
priorityDate 1994-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID299606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446872
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UP87
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12961636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450013327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA1KZ92
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 35.